• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高剂量和低剂量乙酰水杨酸对首次成功冠状动脉成形术后再狭窄率的影响]

[Effects of high and low doses of acetylsalicylic acid on the restenosis rate after initially successful coronary angioplasty].

作者信息

Schanzenbächer P, Grimme M, Walter U, Kochsiek K

机构信息

Medizinische Klinik, Universität Würzburg.

出版信息

Dtsch Med Wochenschr. 1991 Mar 29;116(13):481-5. doi: 10.1055/s-2008-1063636.

DOI:10.1055/s-2008-1063636
PMID:2007377
Abstract

A comparison was made in 79 patients (63 men, 16 women: mean age 52 +/- 9 years) of the effect of high and low doses of aspirin on restenosis rate during the first six months after originally successful percutaneous transluminal coronary angioplasty (PTCA), 39 patients (group 1) received 1000 mg aspirin daily, while 40 (group 2) received 100 mg daily. All patients took 1000 mg aspirin as loading dose on the day before PTCA, and additionally calcium antagonists and slow-release nitrates in the post-PTCA period. Both groups were comparable with respect of localization of the dilated coronary artery stenosis and the morphological changes after dilatation. Intimal lesions after PTCA were demonstrated in 9 patients of group 1 and 10 of group 2. Within six months clinically significant restenosis had occurred in 8 patients of group 1 and 7 of group 2. 33 patients in group 2 and 31 in group 1 were free of symptoms and had no ischaemic reaction on the exercise ECG six months after the initial successful PTCA. These results demonstrate that high aspirin dosage does not reduce the restenosis rate more than low dosage.

摘要

对79例患者(63例男性,16例女性:平均年龄52±9岁)进行了比较,观察高剂量和低剂量阿司匹林对最初成功的经皮腔内冠状动脉成形术(PTCA)后前六个月再狭窄率的影响。39例患者(第1组)每日服用1000毫克阿司匹林,而40例(第2组)每日服用100毫克。所有患者在PTCA前一天服用1000毫克阿司匹林作为负荷剂量,并且在PTCA后期间额外服用钙拮抗剂和缓释硝酸盐。两组在扩张冠状动脉狭窄的部位和扩张后的形态学变化方面具有可比性。第1组9例患者和第2组10例患者在PTCA后出现内膜病变。在六个月内,第1组8例患者和第2组7例患者发生了具有临床意义的再狭窄。在最初成功的PTCA六个月后,第2组33例患者和第1组31例患者无症状,运动心电图上无缺血反应。这些结果表明,高剂量阿司匹林并不比低剂量更能降低再狭窄率。

相似文献

1
[Effects of high and low doses of acetylsalicylic acid on the restenosis rate after initially successful coronary angioplasty].[高剂量和低剂量乙酰水杨酸对首次成功冠状动脉成形术后再狭窄率的影响]
Dtsch Med Wochenschr. 1991 Mar 29;116(13):481-5. doi: 10.1055/s-2008-1063636.
2
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
N Engl J Med. 1988 Jun 30;318(26):1714-9. doi: 10.1056/NEJM198806303182603.
3
[Preventive mechanisms and effects of pemirolast potassium on restenosis after percutaneous transluminal coronary angioplasty: serial coronary angiography and intravascular ultrasound studies].[吡嘧司特钾对经皮腔内冠状动脉成形术后再狭窄的预防机制及效果:系列冠状动脉造影和血管内超声研究]
J Cardiol. 1999 Feb;33(2):81-8.
4
Ketanserin prevents early restenosis following percutaneous transluminal coronary angioplasty.酮色林可预防经皮腔内冠状动脉成形术后的早期再狭窄。
Clin Physiol Biochem. 1990;8 Suppl 3:101-7.
5
[Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].[布拉格综合医学院医院心脏中心对急性心肌梗死患者进行直接经皮腔内冠状动脉成形术:一项为期1年的回顾性研究]
Vnitr Lek. 2002 May;48(5):373-9.
6
Enalapril for prevention of restenosis after coronary angioplasty.依那普利预防冠状动脉成形术后再狭窄
Indian Heart J. 1993 Nov-Dec;45(6):469-73.
7
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.幽门螺杆菌(H. pylori)感染与冠状动脉疾病:经皮冠状动脉腔内血管成形术后幽门螺杆菌根除对冠状动脉管腔的影响。人冠状动脉粥样硬化斑块中幽门螺杆菌特异性DNA的检测。
J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31.
8
A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis.经皮腔内冠状动脉成形术成功后,纤溶酶原激活物抑制剂-1活性降低与冠状动脉再狭窄风险显著降低相关。
Thromb Haemost. 1992 Feb 3;67(2):209-13.
9
Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis.热休克蛋白-65抗体与经皮腔内冠状动脉成形术及后续再狭窄的关联。
Thromb Haemost. 1996 Feb;75(2):258-60.
10
[Percutaneous revascularization with coronary angioplasty in patients with refractory angina].[难治性心绞痛患者经皮冠状动脉血管重建术与冠状动脉成形术]
Rev Esp Cardiol. 1996 Nov;49(11):826-33.